International Medical Press (IMP) is a provider of independent continuing medical education with a 20-year history of delivering multi-format and multidisciplinary education. With a considerable breadth and depth of therapeutic expertise in the areas of diabetes, cardiometabolic risk, critical care, infectious diseases, and osteoporosis. IMP produces accurate, clinically relevant , unbiased content guaranteed through extensive content review processes. IMP’s continuing education providers units are accredited by the ACCME, ANCC, and ACPE and our staff are recognized as experts in the CME enterprise.
International Medical Press
October 28, 2008
This activity is intended for infectious disease physicians, researchers, scientists, and other healthcare providers with an interest in infectious diseases.
International Medical Press
Location:
This is a web-based enduring material CME
Course Directors/Instructors:
Frederick Hayden, MD
Stuart S. Richardson Professor of Clinical Virology
Professor of Medicine and Pathology
Departments of Medicine and Pathology
University of Virginia School of Medicine
Charlottesville, Virginia, USA
Anthony Fiore, MD, MPH, CAPT, USPHS
Associate Chief, Policy Development and Liaison Activities
Epidemiology and Prevention Branch, Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia, USA
David S.C. Hui, MBBS, MD, FRACP, FRCP, FCCP, FHKCP, FHKAM
Professor, Department of Medicine & Therapeutics
Head of Division of Respiratory Medicine
Deputy Director, Stanley Ho Center for Emerging Infectious Diseases
The Chinese University of Hong Kong
Prince of Wales Hospital
Shatin, Hong Kong SAR, China
Registration Fees: Free
1.5 AMA PRA Category 1 Credit(s)™
Link
Brochure
Detailed Description:
An increase in pediatric deaths, emergence of influenza strains resistant to current antiviral treatments, and ongoing reports of human cases of highly pathogenic avian influenza have heightened awareness that influenza is not always a mild, self-limiting disease. These developments have renewed interest in better diagnostic tests and treatments for influenza infection. Further, there is great interest among CDC and WHO officials in improving clinical outcomes in patients with severe influenza illness.
This symposium will address the multifaceted challenges of influenza management in view of recent guideline updates. The practical clinical management of severe influenza illness will be emphasized and illustrated through case studies from actual patients. Current thinking on the pandemic potential of different viruses and pandemic planning will be reviewed. Finally, new antiviral agents in development will be discussed in view of the alarming increase in viral resistance to existing neuraminidase inhibitors.
